Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer.
暂无分享,去创建一个
M. Venturini | L. Del Mastro | P. Ghiorzo | P. Pronzato | I. Casciano | M. Romani | F. Carli | C. Bighin | A. Levaggi | G. Allemanni | B. Gatteschi | B. Banelli | A. di Vinci | A. Vinci | S. Salvi | L. D. Mastro | Marco Venturini | Massimo Romani | Beatrice Gatteschi | Sandra Salvi | Paolo Pronzato
[1] M. Ringnér,et al. Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs , 2008, BMC clinical pathology.
[2] J. Squire,et al. Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization. , 2007, Neoplasia.
[3] F. Vicini,et al. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in‐breast failure in patients with early‐stage breast cancer treated with breast‐conserving therapy , 2007, Cancer.
[4] F. Vicini,et al. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. , 2005, American journal of clinical pathology.
[5] I. Casciano,et al. p16INK4a promoter methylation and protein expression in breast fibroadenoma and carcinoma , 2005, International journal of cancer.
[6] B. Bonanni,et al. Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution , 2004, Cancer.
[7] P. S. Larson,et al. Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] E. Kliewer,et al. Incidence of Second Primary Breast Cancer Among Women with a First Primary in Manitoba, Canada , 2001, Breast Cancer Research and Treatment.
[9] J. Andersen,et al. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. , 2000, American journal of surgery.
[10] W. Thompson,et al. Epidemiology of contralateral breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] D. Rimm,et al. Polymerase chain reaction‐based detection of clonality as a non‐morphologic diagnostic tool for fine‐needle aspiration of the breast , 1998, Cancer.
[12] A. Pinchera,et al. Polyclonal origin of medullary carcinoma of the thyroid in multiple endocrine neoplasia type 2 , 1997, Human Genetics.
[13] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] B. Henderson,et al. Clonal analysis of bilateral breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] G. Mutter,et al. X chromosome inactivation in the normal female genital tract: implications for identification of neoplasia. , 1995, Cancer research.
[16] S. Hirohashi,et al. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q. , 1995, Cancer research.
[17] F. Mitelman,et al. Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors , 1995, Cancer.
[18] G. Mutter,et al. PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies. , 1995, Nucleic acids research.
[19] J. Fletcher,et al. A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. , 1995, The American journal of pathology.
[20] S. Noguchi,et al. Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis , 1994, Cancer.
[21] L. E. McDonald,et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] P. Gimotty,et al. Bilateral breast cancer: one disease or two? , 1991, Breast Cancer Research and Treatment.
[23] R. Willemze,et al. Studies on clonality by PCR analysis of the PGK-1 gene. , 1991, Nucleic acids research.
[24] S. Groshen,et al. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. , 1989, Surgery.
[25] T. Murad,et al. Bilateral breast cancer. , 1989, The American surgeon.
[26] A. Feinberg,et al. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. , 1985, Science.
[27] B. Hankey,et al. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. , 1983, Journal of the National Cancer Institute.
[28] I. Seidman,et al. Bilateral primary breast cancer. , 1976, JAMA.
[29] G F ROBBINS,et al. Bilateral primary breast cancers. A prospective clinicopathological study , 1964 .
[30] Y. Fukushima,et al. A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR , 1999, Human Genetics.
[31] M. Reiss,et al. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] H. Zoghbi,et al. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.